Comparison of Taurolock solution with heparin as lock solution of tunneled catheters

Read full text Summarise with VIRAT
Authors: Hamad Jeelani, Manzoor Ahmad Parry, Amer Said Alameri, Dalia Moussa, Surabhi Gupta, Arasu Mohan, Ahmed Jalal, Ahmed Hassan, Peter William, Said Qader, Ibrahim Hamdi, Mohammed Shaban
+3 more Sally Samy, Gada Ibrahim, Pola Fikry
Cited by: 0
References: 18

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: The employment of dialysis catheters can result in catheter-related blood stream infections (CRBSI), leads to hospitalization, morbidity, and mortality. Citrate-taurolidine lock solution can lower the occurrence of CRBSI. This study was done to evaluate Citrate-taurolidine lock solution for decreasing CRBSI. MATERIALS AND METHODS: This retrospective study included 89 patients who received hemodialysis for at least 6 months via a tunneled catheter. A comparison was made between patients who were administered TauroLock-Hep500™ (taurolidine, citrate, and heparin) or heparin lock solution for catheter-related infection and catheter dysfunction. RESULTS: In this study, 47 patients received heparin lock-solution and 42 patients received Taurolock lock-solution. During a total of 7560 catheter days, the Taurolock group experienced CRBSI in 3 patients. In contrast, the heparin group had 15 patients with CRBSI over a span of 8140 catheter days. This corresponds to an incidence rate of 0.39 episodes of CRBSI per 1000 catheter days in the Taurolock group and 1.84 episodes per 1000 catheter days in the heparin group. Catheter dysfunction rates were similar in the Taurolock group compared to the heparin lock solution. In addition, in the Heparin group, two patients necessitated catheter removal, whereas no patients in the Taurolock group required catheter removal. CONCLUSION: Our study demonstrates a higher incidence of CRBSI in the Heparin group compared to the Taurolock solution and a similar effectiveness of the Taurolock solution in preventing catheter dysfunction over Heparin.

Fields of Study & Subjects

Central Venous Catheters and Hemodialysis Dialysis and Renal Disease Management Infective Endocarditis Diagnosis and Management

Publication details

Journal / source
Saudi Journal of Kidney Diseases and Transplantation
Volume
37
Issue
1
Pages
48–52
Publication date
1 January 2026
Language
EN